Observational studyMedicine2018

Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study.

Yu-Jui Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.